Tech M&A Weekly Roundup

This week in Tech M&A, several transactions stood out across logistics software, life sciences SaaS, warehouse automation, fiber infrastructure, AI agents, photonics, cybersecurity, and a handful of larger market-moving deals:

• Descartes acquired Idelic for about $28m upfront plus up to $12m in earn-out, adding AI-driven fleet safety and telematics analytics to its logistics software stack.
• Blue Mountain acquired CompuCal, expanding its European footprint and deepening its position in calibration and maintenance software for regulated life sciences environments.
• American Industrial Partners agreed to acquire Honeywell’s Warehouse and Workflow Solutions business, another sign of continued investment in automation and mission-critical workflow technology.
• GCI announced it will acquire Quintillion, strengthening Alaska’s fiber network in a picks-and-shovels connectivity deal tied to growing cloud and AI traffic demand.
• Silo Pharma said it acquired the assets of Qwikagents.ai and launched a dedicated AI subsidiary around the platform, pointing to continued interest in agentic AI as a buy-versus-build category.
• Marvell announced the acquisition of Polariton Technologies, adding photonics IP to support next-generation AI networking and optical interconnect performance.
• ServiceNow completed its $7.75bn acquisition of Armis, one of the biggest recent cybersecurity platform moves, bringing real-time asset intelligence into its workflow and AI control plane.
• Airbus agreed to acquire Quarkslab, reinforcing the sovereign cyber theme in Europe as defense and critical infrastructure buyers continue to add specialized capability.
• QXO agreed to acquire TopBuild for about $17bn, one of the week’s biggest deals and another major scale move in building products distribution and services.
• Blue Owl agreed to acquire Sila Realty Trust for about $2.4bn in cash, highlighting ongoing appetite from private capital for cash-flowing real asset portfolios.
• UCB agreed to acquire Neurona Therapeutics for up to $1.15bn, continuing the trend of buyers paying for differentiated clinical assets.
• Roche entered a merger agreement to acquire SAGA Diagnostics for up to $595m, adding tumor-informed MRD capabilities and reinforcing ongoing consolidation in oncology diagnostics.
• Paramount’s proposed transaction with Warner Bros. Discovery also remained in focus, with shareholders voting on one of the largest potential media combinations in years.

What matters: buyers continue to prioritize assets that deepen workflow ownership, strengthen infrastructure, and add differentiated IP in high-value markets. Across software, cyber, AI infrastructure, and adjacent sectors, the consistent pattern is that strategic relevance and platform fit remain the key drivers of M&A activity.

For CEOs, founders, and investors, that reinforces the value of building businesses with clear integration potential, defensible positioning, and a direct role in a larger strategic roadmap.